Santen Pharmaceutical Co., Ltd. (SNPHY)
OTCMKTS · Delayed Price · Currency is USD
11.22
-0.07 (-0.62%)
Feb 11, 2026, 10:24 AM EST
Santen Pharmaceutical Employees
Santen Pharmaceutical had 3,849 employees as of March 31, 2025. The number of employees increased by 105 or 2.80% compared to the previous year.
Employees
3,849
Change (1Y)
105
Growth (1Y)
2.80%
Revenue / Employee
$477,224
Profits / Employee
$50,703
Market Cap
3.60B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 3,849 | 105 | 2.80% |
| Mar 31, 2024 | 3,744 | -400 | -9.65% |
| Mar 31, 2023 | 4,144 | -171 | -3.96% |
| Mar 31, 2022 | 4,315 | 86 | 2.03% |
| Mar 31, 2021 | 4,229 | 121 | 2.95% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Tian'an Technology Group | 8 |
| OpGen | 1 |
Santen Pharmaceutical News
- 6 days ago - Santen Pharmaceutical Co., Ltd. GAAP EPS of ¥66.05, revenue of ¥210.76B - Seeking Alpha
- 7 weeks ago - Santen Pharmaceutical Launches Verkazia In China For Severe Childhood VKC Treatment - Nasdaq
- 3 months ago - Santen Pharmaceutical reports Q2 results - Seeking Alpha
- 9 months ago - Santen Pharmaceutical Co., Ltd. reports Q4 results - Seeking Alpha
- 3 years ago - Santen Pharmaceutical Co., Ltd. (SNPHY) Management on Q1 2022 Results - Earnings Call Transcript - Seeking Alpha